LUCAFÒ, MARIANNA
 Distribuzione geografica
Continente #
NA - Nord America 3.974
EU - Europa 2.986
AS - Asia 651
AF - Africa 32
SA - Sud America 21
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 2
Totale 7.671
Nazione #
US - Stati Uniti d'America 3.957
PL - Polonia 1.291
IT - Italia 709
SE - Svezia 393
CN - Cina 283
HK - Hong Kong 210
DE - Germania 123
UA - Ucraina 101
BG - Bulgaria 69
IE - Irlanda 66
TR - Turchia 56
FI - Finlandia 55
FR - Francia 39
BE - Belgio 36
SN - Senegal 27
VN - Vietnam 27
GB - Regno Unito 24
KR - Corea 22
RU - Federazione Russa 18
BR - Brasile 14
SG - Singapore 14
CA - Canada 13
CH - Svizzera 10
CZ - Repubblica Ceca 10
IN - India 9
NL - Olanda 8
JP - Giappone 7
PK - Pakistan 6
SI - Slovenia 6
AT - Austria 5
HU - Ungheria 5
MY - Malesia 5
CL - Cile 4
EU - Europa 4
RS - Serbia 4
EG - Egitto 3
MD - Moldavia 3
RO - Romania 3
AR - Argentina 2
AU - Australia 2
DO - Repubblica Dominicana 2
ES - Italia 2
ID - Indonesia 2
IL - Israele 2
LB - Libano 2
MT - Malta 2
NO - Norvegia 2
A1 - Anonimo 1
CU - Cuba 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
MX - Messico 1
NG - Nigeria 1
PE - Perù 1
PH - Filippine 1
SA - Arabia Saudita 1
TW - Taiwan 1
ZA - Sudafrica 1
Totale 7.671
Città #
Warsaw 1.290
Fairfield 563
Chandler 451
Woodbridge 428
Ashburn 342
Trieste 332
Ann Arbor 324
Houston 293
Wilmington 253
Seattle 240
Hong Kong 209
Cambridge 173
Jacksonville 120
Princeton 110
Beijing 78
Sofia 69
Dublin 62
Dearborn 55
Izmir 42
Brussels 36
Boardman 29
Dakar 27
Dong Ket 26
Falls Church 23
Redwood City 23
San Diego 23
Seoul 20
Helsinki 19
Munich 18
Shanghai 18
Milan 17
Bremen 15
Des Moines 14
Rome 14
Hefei 13
Udine 13
Guangzhou 11
Brno 10
Jinan 10
Mestre 10
Nanjing 10
Shenyang 10
Washington 10
Bern 9
Redmond 9
Dallas 8
Kocaeli 8
Kunming 8
Los Angeles 8
Norwalk 8
Chicago 7
Fano 7
Phoenix 7
Pignone 7
Scafati 7
Changsha 6
Chengdu 6
Hebei 6
Lappeenranta 6
Monfalcone 6
Singapore 6
Ariano Irpino 5
Budapest 5
Düsseldorf 5
Fogliano Redipuglia 5
Islamabad 5
Nanchang 5
São Paulo 5
Torre Del Greco 5
Amsterdam 4
Boulder 4
Fremont 4
Guangdong 4
Guelph 4
Haikou 4
Lanzhou 4
Ljubljana 4
Pune 4
Sesto al Reghena 4
Toronto 4
Venice 4
Vienna 4
Andover 3
Atlanta 3
Belgrade 3
Bologna 3
Cividale del Friuli 3
Costa Mesa 3
Detroit 3
Dongguan 3
Edinburgh 3
Fuzhou 3
Indiana 3
London 3
Montebelluna 3
Novara 3
Nürnberg 3
Paris 3
Pordenone 3
Renton 3
Totale 6.128
Nome #
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 397
Long Noncoding RNA GAS5: A Novel Marker Involved in Glucocorticoid Response 366
Pharmacogenetics of thiopurines 363
Glucocorticoid pharmacogenetics in pediatric idiopathic nephrotic syndrome 338
High-throughput sequencing of microRNAs in glucocorticoid sensitive paediatric inflammatory bowel disease patients 319
Identification and Characterization of a Novel Family of Cysteine-Rich Peptides (MgCRP-I) from Mytilus galloprovincialis 278
Azathioprine Biotransformation in Young Patients with Inflammatory Bowel Disease: Contribution of Glutathione-S Transferase M1 and A1 Variants 248
Carbamazepine-induced thrombocytopenic purpura in a child: Insights from a genomic analysis 246
Expression Pattern of Long Non-Coding RNA Growth Arrest-Specific 5 in the Remission Induction Therapy in Childhood Acute Lymphoblastic Leukemia 242
New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles. 224
A Cationic [60] Fullerene Derivative Reduces Invasion and Migration of HT-29 CRC Cells in Vitro at Dose Free of Significant Effects on Cell Survival 214
Pharmacotranscriptomic Biomarkers in Glucocorticoid Treatment of Pediatric Inflammatory Bowel Disease 196
Role of the Long Non-Coding RNA Growth Arrest-Specific 5 in Glucocorticoid Response in Children with Inflammatory Bowel Disease 189
Pharmacogenetics of treatments for inflammatory bowel disease 186
Pro-inflammatory effects of palytoxin: An: in vitro study on human keratinocytes and inflammatory cells 176
Glucocorticoid Receptor Interacting Co-regulators: Putative Candidates for Future Drug Targeting Therapy 167
Induced pluripotent stem cells for therapy personalization in pediatric patients: Focus on drug-induced adverse events 167
MicroRNAs as tools to predict glucocorticoid response in inflammatory bowel diseases. 162
Long non-coding RNA gas5 and intestinal mmp2 and mmp9 expression: A translational study in pediatric patients with IBD 156
Hydrophilic polymer coated monodispersed Fe3O4 nanostructures and their cytotoxicity 153
Imidazo[2,1-b]benzothiazol derivatives as potential allosteric inhibitors of the glucocorticoid receptor 147
Determination of Serum Infliximab Concentration by Point-of-care Devices in Children with Inflammatory Bowel Disease 144
RNA-seq analysis of the whole transcriptome of MDA-MB-231 mammary carcinoma cells exposed to the antimetastatic drug NAMI-A 143
Pharmacogenetic determinants of response to infliximab in pediatric inflammatory bowel disease 134
Emerging Insights on the Interaction Between Anticancer and Immunosuppressant Drugs and Intestinal Microbiota in Pediatric Patients 132
Risk Factors and Outcomes of Thalidomide-induced Peripheral Neuropathy in a Pediatric Inflammatory Bowel Disease Cohort 130
Therapeutic drug monitoring to improve outcome of anti-TNF drugs in pediatric inflammatory bowel disease 127
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 124
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 122
Differential expression of GAS5 in rapamycin-induced reversion of glucocorticoid resistance 119
Pharmacokinetics and pharmacodynamics of thiopurines in an in vitro model of human hepatocytes: Insights from an innovative mass spectrometry assay 119
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 118
Emerging molecular mechanisms underlying cancer metastasis: the rising role of the long non-coding RNA GAS5 117
MICRORNAS ARE INVOLVED IN GLUCOCORTICOID RESISTANCE REVERSION BY RAPAMYCIN THROUGH SUPPRESSION OF THE JNK SIGNALING PATHWAY 90
The non-euphoric phytocannabinoid cannabidivarin counteracts intestinal inflammation in mice and cytokine expression in biopsies from UC pediatric patients 84
Interplay of OpdP Porin and Chromosomal Carbapenemases in the Determination of Carbapenem Resistance/Susceptibility in Pseudomonas aeruginosa 73
miR-331-3p is involved in glucocorticoid resistance reversion by rapamycin through suppression of the MAPK signaling pathway 72
Microbiota and drug response in inflammatory bowel disease 70
Genome wide association studies for treatment-related adverse effects of pediatric acute lymphoblastic leukemia 69
Role of tristetraprolin phosphorylation in paediatric patients with inflammatory bowel disease 64
MIF plasma level as a possible tool to predict steroid responsiveness in children with idiopathic nephrotic syndrome 63
Biomarkers and Precision Therapy for Primary Immunodeficiencies: An In Vitro Study Based on Induced Pluripotent Stem Cells From Patients 63
Responses of patients with juvenile idiopathic arthritis to methotrexate: a genomic outlook 63
Atomic Force Microscopy Application for the Measurement of Infliximab Concentration in Healthy Donors and Pediatric Patients with Inflammatory Bowel Disease 58
Sedation and analgesia in children with cerebral palsy: a narrative review 54
Serum Adalimumab Levels After Induction Are Associated With Long-Term Remission in Children With Inflammatory Bowel Disease 51
Theophylline as a precision therapy in a young girl with PIK3R1 immunodeficiency 50
Inflammatory Bowel Disease and Risk of Colorectal Cancer: An Overview From Pathophysiology to Pharmacological Prevention 48
Hypomethylation of NLRP3 gene promoter discriminates glucocorticoid-resistant from glucocorticoid-sensitive idiopathic nephrotic syndrome patients 47
A patent review of anticancer glucocorticoid receptor modulators (2014-present) 46
Pharmacogenetic variants of infliximab response in young patients with inflammatory bowel disease 45
Extracellular Vesicles as Innovative Tools for Assessing Adverse Effects of Immunosuppressant Drugs 44
Clinical application of thiopurine pharmacogenomics in pediatrics 42
Patient-derived organoids for therapy personalization in inflammatory bowel diseases 41
Gender May Influence the Immunosuppressive Actions of Prednisone in Young Patients With Inflammatory Bowel Disease 41
Gene expression profiling in white blood cells reveals new insights into the molecular mechanisms of thalidomide in children with inflammatory bowel disease 39
Neutralization of extracellular NAMPT (nicotinamide phosphoribosyltransferase) ameliorates experimental murine colitis 35
PACSIN2 as a modulator of autophagy and mercaptopurine cytotoxicity: mechanisms in lymphoid and intestinal cells 32
Insights into the cellular pharmacokinetics and pharmacodynamics of thiopurine antimetabolites in a model of human intestinal cells 31
Pharmacogenomics of antibiotics 30
A Validated HPLC-Diode Array Detection Method for Therapeutic Drug Monitoring of Thiopurines in Pediatric Patients: From Bench to Bedside 27
Subcutaneous tocilizumab in the management of non-infectious uveitis in children: a brief report 22
Causes of Treatment Failure in Children With Inflammatory Bowel Disease Treated With Infliximab: A Pharmacokinetic Study 19
Expression profiles of the lncRNA antisense GAS5-AS1 in colon biopsies from pediatric inflammatory bowel disease patients and its role in regulating sense transcript GAS5 18
iPSCs as a groundbreaking tool for the study of adverse drug reactions: A new avenue for personalized therapy 18
DNA methylation of the TPMT gene and azathioprine pharmacokinetics in children with very early onset inflammatory bowel disease 15
SERS spectroscopy as a tool for the study of thiopurine drug pharmacokinetics in a model of human B leukemia cells 14
Totale 8.041
Categoria #
all - tutte 18.963
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.963


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019309 0 0 0 0 0 0 0 0 0 0 183 126
2019/20201.941 104 107 102 291 141 212 248 201 190 125 137 83
2020/20211.422 126 110 126 116 164 161 159 69 92 137 62 100
2021/2022901 63 51 54 80 40 85 78 28 100 89 36 197
2022/20231.324 120 215 94 197 115 209 15 119 129 27 48 36
2023/2024842 48 51 37 47 93 97 185 212 31 35 6 0
Totale 8.041